Sign in
Active, not recruitingPhase 4

Bicarbonate for In-Hospital Cardiac Arrest

Key facts

Who runs it
Lars Wiuff Andersen
Where
Denmark22 sites in 1 countryChoose a country to see its sites
Trial code
Status
Active, not recruiting
Phase
Phase 4
People taking part
778 people, planned
Started
6 Feb 2023
Expected to end
11 Feb 2027
Type of study
Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
Treatments tested
  • Sodium bicarbonate
  • Sodium chloride
Record updated
17 February 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • In-hospital cardiac arrest
  • Age ≥ 18 years
  • Received at least one dose of adrenaline during cardiopulmonary resuscitation (CPR)

Who cannot take part

  • Clearly documented "do-not-resuscitate" order prior to the cardiac arrest
  • Prior enrollment in the trial
  • Invasive mechanical circulatory support at the time of the cardiac arrest
  • Known or suspected pregnancy at the time of the cardiac arrest
  • Known objection by the patient to participate in the trial
  • Clinical indication for bicarbonate administration

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This is an investigator-initiated, multicenter, randomized, placebo-controlled, parallel group, double-blind, superiority trial of sodium bicarbonate during adult in-hospital cardiac arrest. There will be 22 enrolling sites in Denmark. 778 adult patients with in-hospital cardiac arrest receiving at least one dose of adrenaline will be enrolled. The primary outcome is return of spontaneous circulation and key secondary outcomes include survival at 30 days and survival at 30 days with a favorable neurological outcome.

The 2 groups in the trial

  • Sodium bicarbonateTreatment being tested

    50 ml of 1 mmol/ml sodium bicarbonate given as soon as possible after the first dose of adrenaline. If the patient remains in cardiac arrest, one additional dose of 50 ml of 1 mmol/ml sodium bicarbonate will be administered after the second dose of adrenaline dose for a maximum of two doses.

  • PlaceboPlacebo, for comparison

    50 mL of 9 mg/mL NaCl ("normal saline") given as soon as possible after the first dose of adrenaline. If the patient remains in cardiac arrest, one additional dose of 50 mL of 9 mg/mL NaCl will be administered after the second dose of adrenaline dose for a maximum of two doses.

    Treatment: Sodium chloride

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Bicarbonate for In-Hospital Cardiac Arrest - A Randomized, Double-Blind, Placebo-Controlled Trial
Publications
Record updated
17 February 2026